Ayala PharmaceuticalsADXS
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.33avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Ayala Pharmaceuticals Inc. (ADXS) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Vermillion & White Wealth Management Group, LLC ($1).
- Company
- Ayala Pharmaceuticals Inc.
- CUSIP
- 007624406
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Vermillion & White Wealth Management Group, LLC | 0.00% | No change | 3 | $1 |
"% of holder's portfolio" is ADXS's weight in each manager's 13F, not the share of Ayala Pharmaceuticals Inc. the manager owns.